Work

Kme-0584, a Highly Potent IRAK1/IRAK4/panFLT3 Inhibitor, Is a Promising Clinical Candidate for Hypomethylating Agent Plus Venetoclax Resistant AML/MDS Patients

Year: 2023

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2023-189899

Authors: Jan S. Rosenbaum, Amal S. Kolt, Scott B. Hoyt, Gregory M. Hayes, Brandi L. Soldo, Craig J. Thomas, Daniel T. Starczynowski

Institutions: National Institutes of Health, National Center for Advancing Translational Sciences, Cincinnati Children's Hospital Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389248290

Cites:

Cited by: 5

Related to: 10